6 hasil untuk "Mathieu Chevallier"
Menampilkan 1–6 · 0,34 detik · RSS
-
Artikel Jurnal
Pleural Mesothelioma in the Era of Immunotherapy
Over the course of the last decade, immunotherapy has revolutionised the management of a great number of cancer types. The treatment of pleural mesothelioma, a rare and highly aggressive cancer, is also being transformed by immunotherapy. The recent combination of ipilimumab and nivolumab improved…
-
Artikel Jurnal
Oncogenic driver mutations in non-small cell lung cancer: Past, present and future
are discussed, as well as agents targeting these alterations. Current standards of treatment as well as promising future strategies are presented. Currently, more than fifteen targeted agents are food and Drug administration-approved for seven oncogenic drivers in non-small-cell lung cancer…
-
Artikel Jurnal
Vertebral Metastasis Treated by Vertebroplasty, a Cause of Respiratory Failure: Case Report and Literature Review
Bone is a frequent site of metastases in advanced cancers including lung, breast, prostate, kidney, or myeloma. Lesions are commonly located on the spine. Neoplastic invasion of the vertebral body can result in painful vertebral fractures, leading to disability and substantial morbidity…
-
Artikel Jurnal
Antibody-Drug Conjugates in the Treatment of Metastatic Breast Cancer: The Emerging Questions of Sequence and Resistance
Metastatic breast cancer continues to present significant therapeutic challenges, necessitating ongoing exploration of innovative treatments. The use of antibody-drug conjugates (ADCs) represents an effective treatment strategy that combines the targeting capabilities of monoclonal antibodies with…
-
Artikel Jurnal
The Impact of Variant Allele Frequency in EGFR Mutated NSCLC Patients on Targeted Therapy
EGFR mutations represent the most common currently targetable oncogenic driver in non-small cell lung cancer. There has been tremendous progress in targeting this alteration over the course of the last decade, and third generation tyrosine kinase inhibitors offer previously unseen survival rates…
-
Artikel Jurnal
Rare Synchronous Lung Cancers in a Nonsmoker with Epidermal Growth Factor Receptor and Mesenchymal-Epithelial Transition Alterations: A Case Report
Introduction: Lung cancer is the second most common cancer; however, synchronous lung cancer is rare and challenging to treat. Case Presentation: We report the case of an 80-year-old female patient who presented with two lung lesions with primary tumor characteristics, which revealed squamous cell…